Scanxiety and tumour marker-related anxiety in people with cancer: experiences of genitourinary cancer nurses

2021 ◽  
Vol 22 (3) ◽  
Author(s):  
Kim Bui ◽  
Belinda Kiely ◽  
Chris Brown ◽  
Prunella Blinman ◽  
Haryana Dhillon
Keyword(s):  
Tumour Marker ◽  
Genitourinary Cancer ◽  
Cancer Nurses

Value of BNP and tumour marker CA125 in patients with heart failure

2008 ◽  
Vol 63 (4) ◽  
pp. 501-506 ◽  
Author(s):  
Y-X. Chen ◽  
X-Q. Wang ◽  
C-F. Fang ◽  
J-F. Wang ◽  
L-J. Tang
Keyword(s):  
Heart Failure ◽  
Tumour Marker ◽  
Patients With Heart Failure

MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential

2019 ◽  
Vol 16 (5) ◽  
pp. 318-328 ◽  
Author(s):  
Justin C. Penticuff ◽  
Benjamin L. Woolbright ◽  
Thais M. Sielecki ◽  
Scott J. Weir ◽  
John A. Taylor
Keyword(s):  
Therapeutic Potential ◽  
Genitourinary Cancer

scholarly journals Racial Differences in Incident Genitourinary Cancer Cases Captured in the National Cancer Database

Medicina ◽  
2021 ◽  
Vol 57 (7) ◽  
pp. 671
Author(s):  
Dylan T. Wolff ◽  
Thomas F. Monaghan ◽  
Danielle J. Gordon ◽  
Kyle P. Michelson ◽  
Tashzna Jones ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
United States ◽  
Bladder Cancer ◽  
Kidney Cancer ◽  
The United States ◽  
Coverage Rate ◽  
National Cancer Database ◽  
Genitourinary Cancer ◽  
Coverage Rates ◽  
Capture Rates

Background and Objectives: The National Cancer Database (NCDB) captures nearly 70% of all new cancer diagnoses in the United States, but there exists significant variation in this capture rate based on primary tumor location and other patient demographic factors. Prostate cancer has the lowest coverage rate of all major cancers, and other genitourinary malignancies likewise fall below the average NCDB case coverage rate. We aimed to explore NCDB coverage rates for patients with genitourinary cancers as a function of race. Materials and Methods: We compared the incidence of cancer cases in the NCDB with contemporary United States Cancer Statistics data. Results: Across all malignancies, American Indian/Alaskan Natives subjects demonstrated the lowest capture rates, and Asian/Pacific Islander subjects exhibited the second-lowest capture rates. Between White and Black subjects, capture rates were significantly higher for White subjects overall and for prostate cancer and kidney cancer in White males, but significantly higher for bladder cancer in Black versus White females. No significant differences were observed in coverage rates for kidney cancer in females, bladder cancer in males, penile cancer, or testicular cancer in White versus Black patients. Conclusions: Differential access to Commission on Cancer-accredited treatment facilities for racial minorities with genitourinary cancer constitutes a unique avenue for health equity research.

Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma

2004 ◽  
Vol 91 (2) ◽  
pp. 242-247 ◽  
Author(s):  
A. J. Hayes ◽  
A. Mostyn-Jones ◽  
M. U. Koban ◽  
R. A'Hern ◽  
P. Burton ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Tumour Marker ◽  
Vascular Endothelial ◽  
Endothelial Growth Factor

Estimation of Serum MicroRNA 21 as a Tumour Marker in Carcinoma Oesophagus

2021 ◽  
Author(s):  
Sruthy Harshan ◽  
Lancelot Lobo ◽  
Suchetha Kumari ◽  
Shilpa Shetty
Keyword(s):  
Tumour Marker ◽  
Serum Microrna ◽  
Carcinoma Oesophagus

CURRENT GENITOURINARY CANCER SURGERY

1991 ◽  
Vol 21 (4) ◽  
pp. 492-492
Author(s):  
Michael Friedlander
Keyword(s):  
Cancer Surgery ◽  
Genitourinary Cancer
Sign in / Sign up

Export Citation Format

Share Document